A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy.
A trivariate continual reassessment method for phase I/II trials of toxicity, efficacy, and surrogate efficacy.
复制标题
DOI:
10.1002/sim.5477
复制
发表时间:
2012-12-20
影响因子:
2
通讯作者:
Carlin, Bradley P.
中科院分区:
文献类型:
--
作者:
Zhong, Wei;Koopmeiners, Joseph S.;Carlin, Bradley P.
关键词:
Recently, many Bayesian methods have been developed for dose-finding when simultaneously modeling both toxicity and efficacy outcomes in a blended phase I/II fashion. A further challenge arises when all the true efficacy data cannot be obtained quickly after the treatment, so that surrogate markers are instead used (e.g, in cancer trials). We propose a framework to jointly model the probabilities of toxicity, efficacy and surrogate efficacy given a particular dose. Our trivariate binary model is specified as a composition of two bivariate binary submodels. In particular, we extend the bCRM approach, as well as utilize the Gumbel copula of Thall and Cook. The resulting trivariate algorithm utilizes all the available data at any given time point, and can flexibly stop the trial early for either toxicity or efficacy. Our simulation studies demonstrate our proposed method can successfully improve dosage targeting efficiency and guard against excess toxicity over a variety of true model settings and degrees of surrogacy.
登录
查看更多内容
影响因子:
1.9
作者:
STORER, BE
通讯作者:
STORER, BE
影响因子:
2
作者:
Zhang, Wei;Sargent, Daniel J.;Mandrekar, Sumithra
通讯作者:
Mandrekar, Sumithra
影响因子:
1.9
作者:
OQUIGLEY, J;PEPE, M;FISHER, L
通讯作者:
FISHER, L
影响因子:
2
作者:
Li, Yisheng;Bekele, B. Nebiyou;Cook, John D.
通讯作者:
Cook, John D.
影响因子:
1.9
作者:
Gasparini, M;Eisele, J
通讯作者:
Eisele, J